The effects of parenteral prostacyclin therapy as add-on treatment to oral compounds in Eisenmenger syndrome Source: Eur Respir J, 54 (5) 1901401; 10.1183/13993003.01401-2019 Year: 2019
Good tolerance of aspirin in Churg-Strauss syndrome Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases Year: 2008
High pulse dose steroids in Severe COVID-19 pneumonitis refractory hypoxemia to dexamethasone Source: Virtual Congress 2021 – Highlights in COVID-19 diagnosis and treatment Year: 2021
Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis Source: ERJ Open Res, 6 (1) 00311-2019; 10.1183/23120541.00311-2019 Year: 2020
Adrenal insufficiency in asthma treated with high/low systemic corticosteroids in the past and in those who sucessfully discontinued systemic corticosteroids after treatment with omalizmab. Source: International Congress 2017 – Management of asthma in different situations Year: 2017
An approach of one-week treatment of inhaled corticosteroid for a diagnosis of asthmatic syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 498s Year: 2006
Predictors of successful oral steroid tapering in severe, prednisone-dependent asthma Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control Year: 2010
Long-term follow-up in Churg-Strauss syndrome following IFN-α-induced remission Source: Annual Congress 2012 - Aspects of clinical asthma Year: 2012
Combination of pentoxifylline and steroids in sarcoidosis treatment Source: Eur Respir J 2005; 26: Suppl. 49, 269s Year: 2005
High-doses glucocorticosteroid treatment in sarcoidosis patients Source: Eur Respir J 2007; 30: Suppl. 51, 118s Year: 2007
Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis Source: Eur Respir J 2014; 43: 602-609 Year: 2013
Efficacy and toxicity of azathioprine plus corticosteroids in 32 patients with chronic persistent sarcoidosis Source: Eur Respir J 2004; 24: Suppl. 48, 712s Year: 2004
Patients‘ reasons for early discontinuation of inhaled corticosteroids and their disease control Source: Eur Respir J 2007; 30: Suppl. 51, 285s Year: 2007
Wegener's granulomatosis after Montelukast in patient not receiving systemic steroid treatment Source: Eur Respir J 2002; 20: Suppl. 38, 65s Year: 2002
Radiation pneumonitis in an infant treated with systemic and inhaled steroids Source: Eur Respir J 2006; 28: Suppl. 50, 90s Year: 2006
Influence of inhaled bronchodilator therapy on bacterioexcretion and LQ in patients with pulmonary TB infection with concomitant broncho-obstructive syndrome Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions Year: 2011
Mechanisms of systemic side effects of inhaled steroids Source: Eur Respir J 2004; 24: Suppl. 48, 347s Year: 2004
Recurrent eosinophilic pneumonia in an asthmatic patient treated with sequential montelukast/zafirlukast after corticosteroid withdrawal Source: Eur Respir J 2002; 20: Suppl. 38, 52s Year: 2002
Oral steroid-sparing effect of high-dose inhaled corticosteroids in asthma Source: Eur Respir J, 55 (1) 1901147; 10.1183/13993003.01147-2019 Year: 2020
High-dose inhalation corticosteroids in conjunction with plasmapheresis in the treatment of patients with acute variant of exogenic allergic alveolitis (EAA) Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura Year: 2012